ORCL
32
3
AAL
56
5
USB
65
6
RIG
57
3
BA
43
-2
CSX
54
4
CMA
70
5
ADSK
57
-2
O
57
2
INTU
53
2
ADP
65
4
CHD
34
2
APA
52
2
SRE
57
-2
EW
55
-2
DE
48
5
AMG
77
2
MAC
61
4
M
37
-3
MAT
56
6
ORCL
32
3
AAL
56
5
USB
65
6
RIG
57
3
BA
43
-2
CSX
54
4
CMA
70
5
ADSK
57
-2
O
57
2
INTU
53
2
ADP
65
4
CHD
34
2
APA
52
2
SRE
57
-2
EW
55
-2
DE
48
5
AMG
77
2
MAC
61
4
M
37
-3
MAT
56
6
Financhill
Back

Leonardo DRS, Inc. 10K Form

Sell
12

DRS
Leonardo DRS, Inc.

Last Price:
$34.32
Seasonality Move:
-2.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DRS News And Ratings

See the #1 stock for the next 7 days that we like better than DRS

DRS Financial Statistics

Sales & Book Value

Annual Sales: $3.2B
Cash Flow: $77M
Price / Cash Flow: 34.27
Annual Sales: $9.95
Price / Book: 3.39

Profitability

EPS (TTM): 0.98590
Net Income (TTM): $265M
Gross Margin: $714M
Return on Equity: 10.31%
Return on Assets: 6.43%

Leonardo DRS, Inc. Earnings Forecast

Key Leonardo DRS, Inc. Financial Ratios

  • The Gross Profit Margin over the past 36 years for DRS is 22.08%.
  • The Selling, General & Administrative Expenses for DRS have been equal to 12.80% of Gross Profit Margin.
  • The Research & Development expenses have been 2.01% of Revenue.
  • The Interest Expense is 9.86% of Operating Income.
  • The Net Earning history of DRS is 6.59% of Total Revenues.
  • Per Share Earnings over the last 36 years have been positive in 15 years.

Leonardo DRS, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Aerospace & Defense
Sector: Industrials
Current Symbol: DRS
Website: leonardodrs.com

Debt

Debt-to-Equity Ratio: 0.18
Current Ratio: 2
Quick Ratio: 1.56

Price-to-Earnings

Trailing P/E Ratio: 42.47
Forward P/E Ratio: 26.85

DRS Technical Analysis vs Fundamental Analysis

Sell
12
Leonardo DRS, Inc. (DRS) is a Sell

Is Leonardo DRS, Inc. a Buy or a Sell?

  • Leonardo DRS, Inc. stock is rated a Sell
    The current Leonardo DRS, Inc. [DRS] share price is $34.31. The Score for DRS is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.